Optimizing linezolid dosing for dialysis patients
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests how best to adjust the dose of an antibiotic called linezolid for people on dialysis. It aims to safely treat infections by using regular blood tests to guide dosing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have advanced kidney disease and be on hemodialysis.
- You cannot be pregnant or breastfeeding.
- You must not have serious liver disease.
- You cannot be taking antidepressants or antipsychotics.
- You must not have blood disorders (like low platelets) or chronic immune thrombocytopenia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a personalized dosing approach for linezolid (an antibiotic) works better than the standard dose. It is for adults with pneumonia or skin/soft tissue infections who have just started or are about to start linezolid.
This trial tests whether adjusting the dose of linezolid based on regular blood tests can help people with multidrug-resistant tuberculosis (MDR-TB) tolerate the medication better while on the BPaL or BPaL-M regimen. It aims to reduce side effects and improve treatment success.
This study checks if measuring the amount of linezolid medicine in your blood helps treat rifampin-resistant tuberculosis more safely and effectively. It is for people who have already started a treatment plan that includes linezolid.
This trial studies how common antibiotics move through the body when someone is on kidney replacement therapy (dialysis), including when dialysis starts during treatment. The results may help doctors choose the right antibiotic dose and timing for better infection treatment.
This trial tests whether adding linezolid, an antibiotic that stops bacteria from making proteins, to usual care works better for treating Staphylococcus aureus bloodstream infections. You may be eligible if you have this infection and are hospitalized.
This study tests different ways to customize the dose of anti-infection medicines in patients very soon after a kidney transplant to find the safest and most effective dosing. It aims to improve recovery and avoid problems with kidney function.
Hear when a new Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.